Asthma improvement in patients treated with dupilumab for severe atopic dermatitis

Asthma improvement in patients treated with dupilumab for severe atopic dermatitis

IntroductionAtopic dermatitis (AD) is considered a systemic type 2 immune driven disease, and it is associated to many atopic comorbidities including asthma. The aim of our study was to prospectively evaluate the respiratory outcomes in patients with persistent allergic asthma treated with dupilumab...

Full description

Bibliographic Details
Main Authors: Marco Dubini, Valentina Benzecry, Federica Rivolta, Andrea Sangalli, Angelo Valerio Marzano, Valerio Pravettoni, Simona Tavecchio, Silvia Mariel Ferrucci
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Allergy
Subjects:
dupilumab
asthma
atopic dermatitis
atopic comorbidities
type 2 disease
allergic asthma
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2023.1223657/full

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2023.1223657/full

Similar Items